Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Biotechnology

Gennao Bio

Gennao Bio's headquarters in Hopewell, NJ, United States

Chris Duke

John Heyburn

Bradley Campbell

Elias Quijano

Peter Glazer

Julie Hambleton

Peter Thompson

The Research and Development team at Gennao Bio focuses on advancing the company's proprietary GMAB platform technology to develop innovative genetic medicines. Comprised of experts in pharmacology, molecular and cell biology, and bioanalytics, the team conducts in-depth research, preclinical studies, and formulates new therapeutics to target and treat genetic disorders effectively.

Research and Development

The Leadership Team at Gennao Bio is responsible for strategic decision-making and guiding the company’s vision in developing innovative genetic medicines. Comprising co-founders and key executives, the team focuses on advancing the proprietary GMAB platform technology, driving research and development, securing funding, and fostering partnerships to bring targeted nucleic acid therapeutics to market. Their collaborative efforts ensure that the company remains at the forefront of genetic medicine innovation.

Gennao Bio

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Similar companies